Brian Sun

Brian Sun, M.S., J.D.

Senior Vice President, General Counsel and Corporate Secretary

Mr. Sun serves as senior vice president, general counsel and corporate secretary for Turning Point Therapeutics. He is responsible for leading the legal function and has nearly 15 years of experience representing public and private biotechnology companies in corporate, transactional and intellectual property matters.

Before joining Turning Point Therapeutics, Mr. Sun served as senior vice president, general counsel and corporate secretary for Sorrento Therapeutics, a NASDAQ-listed biopharmaceutical company focused on developing cancer, non-opioid pain and COVID-19 therapies, where he was responsible for managing all of the company’s legal affairs. Prior to Sorrento Therapeutics, Mr. Sun worked at pharmaceutical and biotechnology companies, Prometheus Laboratories and Hologic, and served as outside general counsel to early-stage biotechnology companies. Mr. Sun also previously worked in private practice at Foley & Lardner LLP, serving clients in the life sciences arena.

Mr. Sun holds a J.D. from the University of San Diego School of Law, a M.S. in Biotechnology from Johns Hopkins University, and a B.A. in Molecular and Cell Biology from the University of California, Berkeley.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb